Personnel costs of the manufacture of pharmaceutical products in Czechia 2008-2016

Personnel costs of the manufacture of basic pharmaceutical products and pharmaceutical preparations in the Czech Republic from 2008 to 2016 (in million euros)

by Dennis Schmid, last edited Apr 18, 2019
Personnel costs of the manufacture of pharmaceutical products in Czechia 2008-2016 This statistic shows the annual personnel costs of the manufacture of basic pharmaceutical products and pharmaceutical preparations in the Czech Republic from 2008 to 2016. In 2016, this industry had personnel costs of approximately 194 million euros.
Show more

Personnel costs of the manufacture of basic pharmaceutical products and pharmaceutical preparations in the Czech Republic from 2008 to 2016 (in million euros)

You need to log in to download this statistic
Register for free
Already a member?
Log in
Statista Accounts: Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$49 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom
Statista is a great source of knowledge, and pretty helpful to manage the daily work.
Christof Baron

Christof Baron
CEO, MindShare Germany

Statistics on "Pharmaceutical industry in Italy"
  • Industry overview
The most important statistics
  • Key players
  • International trade
  • Research and development
  • CDMO
  • Forecasts
Discover Statista
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Learn more about how Statista can support your business.
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.